320 results on '"Ayrault, Olivier"'
Search Results
52. Supplementary Table 2 from Atoh1 Inhibits Neuronal Differentiation and Collaborates with Gli1 to Generate Medulloblastoma-Initiating Cells
53. Supplementary Figures 1 - 6 from Silencing of the miR-17∼92 Cluster Family Inhibits Medulloblastoma Progression
54. Supplementary Figure Legend from Silencing of the miR-17∼92 Cluster Family Inhibits Medulloblastoma Progression
55. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
56. Return to quiescence of mouse neural stem cells by degradation of a proactivation protein
57. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
58. ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP
59. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence
60. Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.
61. Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma
62. Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
63. MEDB-15. Dynamic chromatin alteration induces oncogenic hijacking by essential transcriptional factors during SHH medulloblastoma tumorigenesis
64. ATRT-11. Anatomico-biological correlations define a new layer for ATRT molecular subgroups pointing to potential lineages of origin
65. MODL-07. DNA methylation-based biobank of murine models for pediatric tumors
66. MEDB-84. The French experience of ELP1-related medulloblastomas
67. Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
68. Inhibition of Hsp90 via 17-DMAG Induces Apoptosis in a p53-dependent Manner to Prevent Medulloblastoma
69. SALL4 is a CRL3REN/KCTD11substrate that drives Sonic Hedgehog-dependent medulloblastoma
70. Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
71. Excitatory granule neuron precursors orchestrate laminar localization and differentiation of cerebellar inhibitory interneuron subtypes
72. In vitro and in vivo analysis of the interaction between 5.8S rRNA and ARF protein reveal a new difference between murine p19ARF and human p14ARF
73. Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastoma
74. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes
75. Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
76. ATRT-24. CELL SURFACE PROTEOME ANALYSIS OF ATRT IDENTIFIES TARGETS FOR IMMUNOTHERAPY
77. MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
78. MBRS-51. MUTATIONS IN BRPF1 FOUND IN SHH MEDULLOBLASTOMA PREVENT INTERACTION WITH TP53 AND LEADS TO RADIORESISTANCE IN VITRO
79. MBRS-37. RECURRENT ACTIVATING MUTATIONS OF AKT GENES IN WNT-ACTIVATED MEDULLOBLASTOMAS
80. MBRS-48. IDENTIFICATION OF NOVEL THERAPEUTIC APPROACHES FOR MYC-DRIVEN MEDULLOBLASTOMA
81. Expression of the cell cycle regulators p14 ARF and p16 INK4a in chronic myeloid leukemia
82. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis
83. Functional loss of a noncanonical BCOR–PRC1.1 complex accelerates SHH-driven medulloblastoma formation
84. Functional loss of a non-canonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formation
85. Introduction. Pediatric brain tumor
86. Medulloblastomics revisited: biological and clinical insights from thousands of patients
87. Developmental progression of immunoglobulin heavy chain diversity in sheep
88. Involvement of the transcriptional factor E2F1 in the regulation of the rRNA promoter
89. PDTM-28. AN OTX2-PAX3 SIGNALLING AXIS REGULATES GROUP 3 MEDULLOBLASTOMA CELL FATE
90. An autocrine ActivinB mechanism drives TGF β/Activin signaling in Group 3 medulloblastoma
91. SIG-03. HHIP-AS1 PROMOTES TUMOR SURVIVAL THROUGH STABILIZING DYNEIN COMPLEX 1 IN HEDGEHOG DRIVEN HUMAN BRAIN TUMORS
92. MEDU-42. ELUCIDATING THE ROLE OF STRESS GRANULE FORMATION IN MEDULLOBLASTOMA
93. Atoh1 Controls Primary Cilia Formation to Allow for SHH-Triggered Granule Neuron Progenitor Proliferation
94. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
95. CSIG-15. PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF HUMAN MEDULLOBLASTOMA REVEALS DISTINCT ACTIVATED PATHWAYS BETWEEN SUBGROUPS
96. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
97. NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma
98. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development
99. Erratum: Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I
100. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.